A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP
| Autor: | Takano, Toshimi, Tsurutani, Junji, Takahashi, Masato, Yamanaka, Takeharu, Sakai, Kazuko, Ito, Yoshinori, Fukuoka, Junya, Kimura, Hideharu, Kawabata, Hidetaka, Tamura, Kenji, Matsumoto, Koji, Aogi, Kenjiro, Sato, Kazuhiko, Nishio, Kazuto, Nakagawa, Kazuhiko, Saeki, Toshiaki |
|---|---|
| Zdroj: | In The Breast August 2018 40:67-75 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect